Seeking Alpha
 

Arrowhead Research Corporation (ARWR)

- NASDAQ
  • WItrader18 | Send Message 15 May

    $ARWR $7 cc options expiring today worthless, unless a massive pop comes :)
    Reply
      • WItrader18 | Send Message 7 May

        Sold may 15th covered calls on $ARWR for $0.45 at $7 strike
        Reply (1)
        • delprice | Send Message 12 May
          : same
          • WItrader18 | Send Message 23 Apr

            $SGMO and $ARWR leading the charge today.
            Reply
              • WItrader18 | Send Message 21 Apr

                Increase position 200% in $ARWR at $6.75
                Reply
                  • Clinically Sound Investor | Send Message 15 Apr

                    Buy Arrowhead Research Corporation On The Dip $ARWR http://seekingalpha.com/a/1tu0g
                    Reply
                      • WItrader18 | Send Message 13 Apr

                        $ADMP $ARWR $EPRS all more than 5% gainers on the day. $EPRS was a buy from 4/7
                        Reply
                          • StockConsultant | Send Message 13 Apr

                            $ARWR nice pre market action, large resistance gap, free and clear http://bit.ly/1sl94zD
                            Reply
                              • PrimeBio | Send Message 10 Apr

                                At Arrowhead Research It's Good Technology $ARWR http://seekingalpha.com/p/2bkk8
                                Reply
                                  • StockConsultant | Send Message 7 Apr

                                    $ARWR edging higher, breakout watch above 8.08 http://bit.ly/1sl94zD
                                    Reply
                                      • StockConsultant | Send Message 18 Mar

                                        $ARWR at support area, tool states excellent trade quality (high P/L ratio), http://bit.ly/1sl94zD
                                        Reply
                                          Visit Seeking Alpha's
                                          ARWR vs. ETF Alternatives
                                          Company Description
                                          Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States